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Abstracts / International Journal of Surgery 12 (2014) S13eS117S46resection for metastatic GIST, with relation to the recently proposed pre-
treatment classiﬁcation by Cananzi et al.
Methods: A retrospective case note analysis was performed. Pre-treatment
disease extent was classiﬁed as per Cananzi et al: type I-II non-metastatic,
resectable disease; III metastatic (synchronous) resectable disease; IV
unresectable disease. The primary outcome was 5-year survival; secondary
outcomes were disease free intervals and treatment practices.
Results: Twelve patients underwent liver resection for metastatic GISTs.
Pre-treatment, patients were classiﬁed as: type I in 3; type II in 5; type III in
2; type IV in 2. Five-year survival was 100%, 60%, 50% and 100% respec-
tively. Type I to III patients were treated with surgical resection only. Type
IV disease was downstaged with neo-adjuvant TKIs prior to resection. The
disease free interval was 73, 28, 28 and 53 months respectively (mean 36
months).
Conclusions: Neo-adjuvant TKIs therapy for metastatic GIST has a
potentially signiﬁcant role in improving 5-year survival and disease free
intervals.
0445: A CLOSED LOOP AUDIT DEMONSTRATES GREAT IMPROVEMENT
IN ACUTE PANCREATITIS CARE
Peter Davies*, Hareth Bader, Chris Battersby, Debashish Maitra. St Helens
and Knowsley NHS Trust, Merseyside, UK.
Introduction: The British Society of Gastroenterologists (BSG) updated
guidelinesonthemanagementofacutepancreatitis in2005. Thisaudit aimed
to improve acute pancreatitis care in accordance with those guidelines.
Methods: An initial audit of all 39 patients with acute pancreatitis in
October-December 2011 was undertaken. Improvements were made
through arranging group teaching for junior doctors, extra cholecystec-
tomy lists, a 7-days per week ultrasound service (5-days previously) and
combined microbiology and surgical ward rounds. Liaison with gastroen-
terologists improved ERCP availability. A retrospective re-audit was un-
dertaken of all 50 patients in February-March 2013 to complete the audit
cycle.
Results: Modiﬁed Glasgow Score was completed in 98% of re-audit cases
(85% previously). Antibiotic prescription was considered appropriate in
90% (47%). Gallstone pancreatitis was managed by cholecystectomy, either
as an inpatient or within two weeks, in 77% (10%). Ultrasound was per-
formed within 24 hours of admission in 66% (28%), ERCP was delayed in 2%
(5%) and overall mortality was 8% (10%).
Conclusions: Acute pancreatitis care was improved following several
changes. Current care follows recommended guidelines but there is room
for improvement, notably in improving ultrasound access and managing
gallstone pancreatitis.
0502: POST OPERATIVE SURGICAL DRAINS AFTER PANCREATICODUO-
DENECTOMY: SINGLE VERSUS DUAL DRAINAGE
Jamal Ghaddar*, William Paxton, Chris Briggs, Somaiah Aroori. Derriford
Hospital, Plymouth, UK.
Introduction: The placement of one or more abdominal drains after
pancreaticoduodenectomy is common practice with the rationale that this
facilitates early diagnosis of complications.
Increasing evidence suggests that drainage after abdominal surgeries may
be unnecessary.
Our aim was to evaluate the outcomes following the use of one drain
versus two drains following pancreaticoduodenectomy.
Methods: We retrospectively reviewed 182 patients chosen at random out
of a pool of 260 patients who had a pancreaticoduodenectomy between
2006 and 2013.
Patients were subdivided into two groups; those with one drain (group 1)
and patients with two drains (group 2). Data was then analysed according
to demographic factors such as age/gender and peri-operative factors such
as type of pancreatic anastomosis, date of drain removal, complications,
means used to diagnose and treat complications, length of stay, clinical
details, cancer origin and histology reports.
Results: There were 37 patients in group1 and 145 patients in group2. The
length of hospital stay was signiﬁcantly shorter in group 1 (13.16 vs 15.39
days, P<0.05). There was no statistical difference in the rate of overall
complications, intervention or re-admission in both groups.
Conclusions: The use of one drain after pancreaticoduodencetomy may
facilitate earlier discharge without increasing morbidity, mortality, re-
admission and intervention rate.0728: ROUTINE COAGULATION SCREENING IS UNNECESSARY PRIOR TO
ERCP IN NON-JAUNDICED PATIENTS; A MULTI-CENTRE STUDY
Sarah Walker*,2, Katie Mellor 2, Jonny Nicholls 1, Richard Egan 1,
Michael Stechman 1. 1University Hospital of Wales, Cardiff, UK; 2Princess of
Wales Hospital, Bridgend, UK.
Introduction: Guidelines suggest performing coagulation screening prior
to endoscopic retrograde cholangiopancreatography (ERCP). We
hypothesise that coagulation is rarely deranged in the absence of
biochemical jaundice.
Methods: All ERCP procedures performed at two centres during a 16
month period were assessed. For each patient demographic data, pre-
procedure bilirubin and prothrombin time (PT), diagnosis and bleeding
complications were recorded. Exclusion criteria were; incomplete records,
anti-coagulation therapy or inherited coagulopathy.
Results: The cohort was divided into jaundiced (n¼419) and non-jaun-
diced (n¼374) groups for analysis. Seven per cent (n¼28) of jaundiced
patients had a signiﬁcantly prolonged PT (>16.8 seconds ¼ INR of 1.5).
One non-jaundiced patient had signiﬁcantly prolonged PT, whilst 5.9 per
cent (n¼22) had a mildly raised PT (above normal range); none of these
had bleeding complications. A signiﬁcant difference in PT between groups
was seen (mean ±SD 13.0 ±6.3 vs. 11.0 ±1.2 seconds; p<0.001 t-test). The
diagnosis, ERCP procedures, and bleeding complications were equivalent
between groups and centres. The approximate cost of coagulation tests in
the non-jaundiced cohort was £7,500.
Conclusions: Patients with normal bilirubin levels rarely have deranged
coagulation suggestive of acquired coagulopathy. A negative bleeding
history and normal liver function tests makes coagulation screening an
unnecessary and expensive investigation.
0801: FITNESS TO DRIVE ADVICE AFTER ELECTIVE LAPAROSCOPIC CHO-
LECYSTECTOMY (ELC) e WHOSE RESPONSIBILITY IS IT? A SURVEY OF
CAR INSURANCE COMPANIES
Michael Courtney*, Bussa Gopinath, Duncan Light, Milind Rao. University
Hospital of North Tees, Stockton-on-Tees, UK.
Introduction: Easily accessible online advice regarding return to driving
following ELC is inconsistent. Driving too soon is unsafe and risks inva-
lidating a patient's car insurance; hence patients are often advised to
check their own insurance company's policy. This study aimed to review
UK insurance companies' advice regarding return to driving following
ELC.
Methods: An online search identiﬁed 126 car insurers; each was emailed
asking when the policyholder can return to driving following ELC, and
advice as to how he/she would know they were ﬁt to drive.
Results: 26 companies were not contactable online so excluded. Of the
remaining 100 companies, 62 responded: 61% stated their regulations, 39%
would not communicate without a conﬁrmed policy. All companies of-
fering information stated that a doctor must determine the policyholder's
ﬁtness to drive, or timescale in which they cannot. 1 stated that the poli-
cyholder needed to be able to perform an emergency stop, the rest did not
comment.
Conclusions: Insurance companies place the responsibility of determining
ﬁtness to return to driving with the patient's doctors. It is the doctor's duty
to ensure that patients have access to this information, and that infor-
mation is documented. If publically available information is to be utilised,
there is a need for standardisation.
0843: HEPATIC TRANSARTERIAL CHEMOEMBOLISATION IN EAST
LANCASHIRE: ACHIEVING INTERNATIONAL STANDARDS
Kenan Kursumovic*, Sam Byott, Ambareen Kausar, David Chang,
Neil Wilde, Duncan Gavan. Royal Blackburn Hospital, Blackburn, UK.
Introduction: Hepatic Transarterial Chemoembolisation (TACE) for non-
resectable Hepatocellular carcinoma (HCC) therapy exploits the prefer-
ential blood supply from the hepatic artery for delivery of antitumour
therapy. It is also used for other primary or metastatic liver malignancies.
We enacted a comprehensive review of the TACE service at a district
general hospital in East Lancashire, United Kingdom with a focus on pa-
tient selection, complications and survival rates.
Methods: A retrospective review was performed from 2007 to 2012,
against clinical practice guidelines published by CIRSE (2012) and SIR
(2012).
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treatments (28 patients) for HCC, 19 symptomatic therapies (11 patients)
for metastatic carcinoid tumours and 4 procedures (3 patients) for other
liver metastases. Correct patient selection was achieved in 98% of cases
(SIR/CIRSE threshold: >95%), with a 92 % technical success rate (threshold:
98%) and a 19% overall complication rate (threshold: 15%). >55% of HCC
patients were alive at 20 months follow up (threshold: >50%). Symp-
tomatic relief was achieved in most carcinoid tumour patients.
Conclusions: Our TACE service is generally performing to expected levels
with survival rates in line with international practice guidelines. We
envisage improvements in the technical success and complication rates as
numbers increase.
0913: USE OF HIDA SCANS AND LAPAROSCOPIC CHOLECYSTECTOMY
FOR ACALCULOUS BILIARY SYMPTOMS e A 4 YEAR EXPERIENCE IN A
DISTRICT GENERAL HOSPITAL
A. Jones, G. Fabrizi*, I. Finlay, T. Sulkin. Royal Cornwall Hospital, Truro, UK.
Introduction: Recurrent reproducible RUQ pain in the absence of gall-
stones (acalculous biliary colic) is commonly investigated with a radioac-
tive labelled HIDA scan to look for biliary dyskinesia. Our aimwas to report
on 4 years experience of HIDA scans in the investigation of acalculous
biliary colic and report on ejection fractions, histological changes in any
resected gallbladders, and the efﬁcacy of laparoscopic cholecystectomy as
a treatment for these patients.
Methods: Hospital recordswere interrogated for all patients over the last 4
years who underwent a HIDA scan for investigation of recurrent biliary
symptoms who had no gallstones demonstrable on USS. HIDA scan results
were then combined with histology reports and telephone follow-up to
determine presence of chronic cholecystitis and degree of any symptom-
atic improvement following cholecystectomy.
Results: 26 patients were investigatedwith a HIDA scan; 24 had acalculous
biliary colic. A total of 13 patients underwent cholecystectomy. 12/13 (92%)
had EF<35% and 12/13 (92%) had chronic cholecystitis on histology. 7/7
patients available for long term telephone follow up reported signiﬁcant or
complete improvement in symptoms.
Conclusions: Despite the absence of gallstones on USS, patients with recur-
rent symptoms frequently have histological changes consistent with chole-
cystitis, and cholecystectomy is an appropriate treatment for these patients.
1024: ANALYSIS OF ENDOSCOPIC AND SURGICAL MANAGEMENT OF
COMMON BILE DUCT STONES IN THE LAPAROSCOPIC ERA
Shi Ying Hey*, Peter J. Driscoll, Satheesh Yalamarthi, Andrew J. Robson.
Department of Surgery, Victoria Hospital, Kirkcaldy, UK.
Introduction: Endoscopic retrograde cholangiopancreatography (ERCP)
remains the ﬁrst line intervention for common bile duct stones (CBDS).
Recent popularisation of laparoscopic surgery has extended the treatment
options available for CBDS management, re-opening the debate on the
primary role of ERCP in CBD clearance.
Methods: ERCP records were investigated between January 2006 and April
2011. The outcome of patients who had failed CBDS removal on index ERCP
was reviewed. Complications related to either endoscopic or surgical
procedures were recorded.
Results: 543 patients had CBDS directly visualised. Overall endoscopic
clearance rate was 90.1% (489/543). Of these, 396 (72.9%) patients
had ductal clearance on the ﬁrst ERCP. Of the 147 patients who had a
failed index ERCP, 93/147 was eventually cleared with subsequent
attempts. 11.0% of those that underwent further ERCPs following the
unsuccessful index procedure developed post-ERCP complications. Of
the 147, 30 (20.4%) were referred for surgical clearance, 27/30 underwent
CBD exploration. Of these, 92.6% (25/27) had successful surgical CBD
clearance.
Conclusions: The variable efﬁcacy of therapeutic ERCP in CBDS clearance
remains the main routine drawback and repeating the procedure may not
necessarily optimise the treatment outcome. Surgical exploration should
be considered after the failed index ERCP for CBDS, particularly in the
context of planned laparoscopic cholecystectomy.
1075: THE TIMING OF ENDOSCOPIC RETROGRADE CHOLANGIOPAN-
CREATOGRAPHY AND INPATIENT HOSPITAL STAY AUDIT
Karim Amer*, Diwakar Sarma, Saurav Chakravartty, Avril Chang. King's
College Hospital, London, UK.Introduction: The timing of Endoscopic Retrograde Chol-
angiopancreatography (ERCP) for acute biliary obstruction is not deﬁned
by any national UK guidelines. Recent literature states better patient out-
comes when ERCP is performedwithin 24-48hrs of admission for gallstone
pathology and within 24hrs for severe acute cholangitis. We aim to audit
clinical practice at King's College Hospital London and establishing trust
timing guidelines for ERCP referral.
Methods: Electronic data was collected prospectively and analysed
retrospectively. Audit inclusion criteria identiﬁed inpatient's receiving
ERCP for biliary obstruction between January 2010-2011. Inpatient stay
was compared with timing to ERCP (requested and received <72hrs or
>72hrs upon admission), accounting for reduced weekend services. ERCP
fast-tracking guidelines were presented to both surgical and endoscopy
teams. Re-audit assessing data between April 2011-2012 was completed to
identify service improvement.
Results: A 6% increase was noted in ERCP completed <72hrs. Median total
inpatient stay was 9 days if time to ERCP was <72hrs and 15 days if >72hrs.
The estimated additional cost per-patient if ERCP requested >72hrs is
between £2400-£3900.
Conclusions: Time to ERCP <72hrs of admission signiﬁcantly reduces
inpatient hospital stay thus, consequently improving service delivery
and patient care. A ﬁnancial incentive to reduce time to ERCP is clearly
highlighted.
1344: RISK OF COMMON BILE DUCT STONES WHEN DERANGED LFTS
HAVE RETURNED TO NORMAL
Ayoola Awopetu, Jeremy Williamson, Waseem Hameed, Parinaz Sagni*,
Richard Morgan. Ysbyty Glan Clwyd, North Wales, UK.
Introduction: To investigate the incidence of common bile duct (CBD)
stones in patients who have deranged LFTs which return to normal prior to
cholecystectomy.
Methods: A retrospective review of patients who underwent laparoscopic
cholecystectomy and cholangiography for symptomatic gallstone disease
in a 9 year period, in whom the LFTs had been deranged at presentation,
but had returned to normal prior to surgery.
Results: Some 239 patients underwent laparoscopic cholecystectomy with
operative cholangiogram. All had deranged LFTs at presentation, but normal
LFTs at the time of surgery. 28 had CBD stones (11.7%). Pre-operative CBD
dilatation was found in 63 patients; of these, 12 (19%) had CBD stones.
Conclusions: CBD stones are an unusual ﬁnding in this group of patients
who present with biochemical evidence of a CBD stone, but who appear to
pass the stone. In these patients, CBD stones are more common in patients
with biliary dilatation on pre-operative imaging. Even with a non-dilated
biliary tree, CBD stones are found in a small but clinically signiﬁcant number
of patients. Routine operative cholangiography is therefore recommended
to prevent post-operative problems caused by retained CBD stones.
Maxillofacial surgery
0138: PATIENT KNOWLEDGE ON ORTHOGNATHIC SURGERY
Tara Lee*, John Rowson. Queen's Medical Centre, Nottingham, UK.
Introduction: To ﬁnd out how well informed orthognathic patients felt
they were prior to surgery. To gain insight into the overall patient expe-
rience. To seek feedback on how to improve our service. Design: Retro-
spective audit carried out at Queen’s Medical Centre, Nottingham.
Methods: 66 Questionnaires sent to patients who underwent surgery be-
tween 1/1/2010 and 31/12/2012. 9 Questions were related to patient
knowledge. 4 questions were related to the current orthognathic infor-
mation leaﬂet, how patients preferred information, their use of websites
and their hospital experience. Gold Standard: 90% of patients should report
feeling well informed for each question relating to patient knowledge.
Results: 39 Questionnaires returned. Of the 9 questions related to patient
knowledge- 5 questions surpassed the 90% standard and 4 questions fell
below. The 4 areas where patients felt they needed more informationwere
on recovery time, possibility of wiring jaw together, postoperative dietary
requirements and possibility of relapse.
Conclusions: Most patients felt well informed and had a positive
experience. A revised orthognathic information leaﬂet will be written
placing emphasis on the 4 areas where patients felt less informed. Re-
audit is planned in 2 years to assess the impact of the leaﬂet.
